GLOBUS MEDICAL INC (GMED)

↓ Download CSV

CIK 0001237831 · NYSE · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, GLOBUS MEDICAL INC reported revenue of $2.94B, up 16.7% from the prior year. The company was profitable, with a net margin of 18.3%. It held $5.30B in total assets against $729.51M in total liabilities.

Key ratios (FY2025)

16.3%
Operating margin
18.3%
Net margin
11.8%
Return on equity
+16.7%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$2.94B$2.52B$1.57B$1.02B$958.10M$789.04M$785.37M$712.97M$635.98M$563.99M
Cost of Revenue$957.80M$1.04B$548.17M$263.73M$239.22M$217.46M$179.97M$159.41M$150.45M$134.71M
Gross Profit$1.02B$759.12M$718.88M$571.58M$605.39M$553.56M$485.52M$429.29M
Operating Income$479.82M$165.99M$133.14M$227.95M$171.95M$111.43M$171.99M$169.32M$161.84M$154.14M
Net Income$537.87M$102.98M$122.87M$190.17M$149.19M$102.28M$155.21M$156.47M$107.35M$104.34M
EPS (Diluted)$3.92$0.75$1.07$1.85$1.44$1.01$1.52$1.54$1.10$1.08
Total Assets$5.30B$5.25B$5.09B$2.08B$1.96B$1.68B$1.53B$1.30B$1.08B$927.64M
Total Liabilities$729.51M$1.07B$1.09B$229.75M$215.88M$173.19M$129.62M$115.15M$110.72M$95.56M
Shareholders' Equity$4.57B$4.18B$4.00B$1.85B$1.74B$1.51B$1.40B$1.19B$967.78M$832.08M
Cash & Equivalents$526.16M$784.44M$195.47M$139.65M$118.82M$66.95M
Operating Cash Flow$753.45M$520.64M$243.50M$178.47M$276.27M$198.79M$171.97M$181.64M$159.06M$147.82M
Capital Expenditures$164.68M$115.43M$78.27M$74.05M$56.90M$63.66M$70.75M$59.70M$51.30M$40.91M
Shares Outstanding137.06M137.86M114.63M102.64M103.62M100.97M102.00M101.32M97.89M96.43M